About
The IPO Porto Research Center (CI-IPOP) is the research and development unit of the Portuguese Oncology Institute of Porto (IPO Porto), a leading specialised cancer hospital in Portugal dedicated to patient care, education, and oncology research.
CI-IPOP is recognised by the Portuguese Foundation for Science and Technology (FCT) as an R&D unit and was rated Excellent in the 2019 and 2024 international evaluations. It is a founding member of the RISE Associated Laboratory (Health Research Network), where it coordinates the thematic line dedicated to Clinical and Translational Research in Oncology.
The Centre conducts multidisciplinary research in cancer biology and genetics, molecular oncology, clinical oncology, epidemiology, medical physics, bioimaging, and precision oncology. Its research activities aim to advance cancer prevention, early detection, diagnosis, prognosis, and personalised treatment.
CI-IPOP benefits from close integration with clinical services, research laboratories, and multidisciplinary healthcare teams. Its research environment supports collaborations involving medical imaging, artificial intelligence, machine learning, quantitative biomarkers, predictive modelling, and clinical data analysis.